Real-World Effectiveness of Upadacitinib in Moderate‑to‑Severe Atopic Dermatitis (AD): Results From Longitudinal Analyses of the CorEvitas AD Registry. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 8, n. 6, p. s450, 2024. DOI: 10.25251/skin.8.supp.450. Disponível em: https://skin.dermsquared.com/skin/article/view/3052. Acesso em: 18 may. 2025.